CDC Vaccine Advisors Less Enthusiastic Than White House About Universal COVID Boosters

Focus should remain on primary vaccines and boosters for populations not protected from severe outcomes with initial vaccination, CDC advisors say, potentially contradicting Biden administration plans for widespread allowance of third COVID-19 shots. A booster authorization by the White House’s planned 20 September timeline would also compromise Pfizer’s ability to finish a placebo-controlled study evaluating the impact of its booster on clinical outcomes.